Trump Health Policies Thrust Drug Pricing, Access Back into Spotlight

September 27, 2020

Even advocates of U.S. drug pricing reform recognize that President Trump's revised initiative to reduce the price of prescription drugs is unlikely to save money for consumers or the government.

Trump Escalates Drug Pricing War

September 13, 2020

President Trump has taken on the pharma industry in a surprise move making significant cuts in reimbursement for drugs covered by Medicare.

Extension of Medicare is the Affordable Solution to Current Healthcare Problems

August 24, 2020

COVID-19 has only magnified well known flaws of our healthcare system. An extension of Medicare is the affordable solution, writes Bruno Delagneau, and pharma needs to start planning for this to minimize its impact on US revenues.

Is ICER’s Speed Coming at the Expense of Credibility?

March 19, 2020

The rapid pace of new pharmaceutical approvals raises questions of whether ICER can keep up and maintain the quality and rigor demanded by healthcare audiences, writes Jeremy Schafer.